Class ITerminatedD-837-2013
Drug recall · August 14, 2013
Reumofan Plus recall
Why: Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield, PA, and manufactured by Riger Natural S.A., Mexico.
- Lots / codes
Lot #: 99515, Exp 09/2016
- Quantity
- 586 bottles
- Company
- Reumofan Plus USA, Springfield, PA
- Distribution
- Nationwide through internet sales.
- Initiated
- January 4, 2013 · Voluntary: Firm initiated
- Classified
- August 2, 2013
- Reported
- August 14, 2013
- Ended
- January 29, 2015
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.